Abstract

Acute kidney injury (AKI) is frequently associated with COVID-19 and it is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting in-hospital mortality in COVID-19 patients with AKI (AKI-COV score). This was a cross-sectional multicentre prospective cohort study in the Latin America AKI COVID-19 Registry. A total of 870 COVID-19 patients with AKI defined according to the KDIGO were included between 1 May 2020 and 31 December 2020. We evaluated four categories of predictor variables that were available at the time of the diagnosis of AKI: (1) demographic data; (2) comorbidities and conditions at admission; (3) laboratory exams within 24 h; and (4) characteristics and causes of AKI. We used a machine learning approach to fit models in the training set using tenfold cross-validation and validated the accuracy using the area under the receiver operating characteristic curve (AUC-ROC). The coefficients of the best model (Elastic Net) were used to build the predictive AKI-COV score. The AKI-COV score had an AUC-ROC of 0.823 (95% CI 0.761–0.885) in the validation cohort. The use of the AKI-COV score may assist healthcare workers in identifying hospitalized COVID-19 patients with AKI that may require more intensive monitoring and can be used for resource allocation.

Highlights

  • Acute kidney injury (AKI) is frequently associated with COVID-19 and it is considered an indicator of disease severity

  • The present study aimed to develop and validate a prognostic model for acute kidney injury (AKI) associated with COVID-19 patients using data from the Latin America COVID-AKI R­ egistry[13]

  • The results of the Elastic Net model showed that mechanical ventilation (MV), higher age, vasopressors, higher leukocyte values, higher aspartate aminotransferase (AST) values, severe/moderate condition at admission, hypertension, HA-AKI, AKI aetiology related to sepsis or COVID-19, higher creatinine levels during hospitalisation and indications for Kidney replacement therapy (KRT) were related to a worse outcome

Read more

Summary

Introduction

Acute kidney injury (AKI) is frequently associated with COVID-19 and it is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting in-hospital mortality in COVID-19 patients with AKI (AKI-COV score). This was a cross-sectional multicentre prospective cohort study in the Latin America AKI COVID-19 Registry. The estimated incidence of acute kidney injury (AKI) among patients hospitalized for COVID-19 varies between studies, ranging from 0.5% to as high as 60%4–6. It is important to provide an accurate estimation of mortality in COVID-19 patients with AKI and to explore the differences in these estimations. This approach will improve treatment strategies and facilitate healthcare planning

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call